Natco Pharma is currently trading at Rs. 1013.20, up by 14.70 points or 1.47% from its previous closing of Rs. 998.50 on the BSE.
The scrip opened at Rs. 1000.00 and has touched a high and low of Rs. 1027.45 and Rs. 1000.00 respectively. So far 24372 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1080.00 on 09-Jun-2017 and a 52 week low of Rs. 495.00 on 09-Nov-2016.
Last one week high and low of the scrip stood at Rs. 1027.45 and Rs. 972.15 respectively. The current market cap of the company is Rs. 17456.93 crore.
The promoters holding in the company stood at 51.16%, while institutions and non-institutions held 27.06% and 21.78% respectively.
Natco Pharma has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug formulations facility at Kothur Unit, Telangana, India, during the period Jan 16th - 24th, 2017. This Kothur formulation facility predominantly caters to regulated international markets, including USA.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
